Affimed NV (AFMD)
3.65
-0.08
(-2.28%)
USD |
NASDAQ |
Nov 14, 16:00
3.65
0.00 (0.00%)
After-Hours: 17:39
Affimed Total Assets (Quarterly): 57.00M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 57.00M |
| March 31, 2024 | 76.19M |
| December 31, 2023 | 107.40M |
| September 30, 2023 | 127.51M |
| June 30, 2023 | 146.40M |
| March 31, 2023 | 183.15M |
| December 31, 2022 | 215.03M |
| September 30, 2022 | 232.35M |
| June 30, 2022 | 272.54M |
| March 31, 2022 | 215.69M |
| December 31, 2021 | 254.90M |
| September 30, 2021 | 255.57M |
| June 30, 2021 | 295.15M |
| March 31, 2021 | 317.21M |
| December 31, 2020 | 216.13M |
| September 30, 2020 | 126.72M |
| June 30, 2020 | 113.76M |
| March 31, 2020 | 107.00M |
| December 31, 2019 | 125.86M |
| September 30, 2019 | 93.60M |
| June 30, 2019 | 112.70M |
| March 31, 2019 | 123.91M |
| Date | Value |
|---|---|
| December 31, 2018 | 132.89M |
| September 30, 2018 | 57.02M |
| June 30, 2018 | 68.81M |
| March 31, 2018 | 82.10M |
| December 31, 2017 | 51.78M |
| September 30, 2017 | 53.43M |
| June 30, 2017 | 60.88M |
| March 31, 2017 | 60.96M |
| December 31, 2016 | 51.52M |
| September 30, 2016 | 59.72M |
| June 30, 2016 | 68.57M |
| March 31, 2016 | 80.01M |
| December 31, 2015 | 86.72M |
| September 30, 2015 | 71.04M |
| June 30, 2015 | 78.31M |
| March 31, 2015 | 42.55M |
| December 31, 2014 | 50.96M |
| September 30, 2014 | 60.73M |
| June 30, 2014 | 6.153M |
| March 31, 2014 | 9.692M |
| December 31, 2013 | 8.976M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
57.00M
Minimum
Jun 2024
317.21M
Maximum
Mar 2021
181.35M
Average
183.15M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| InflaRx NV | 99.73M |
| BioNTech SE | 25.02B |
| Immatics NV | 672.05M |
| CureVac NV | 596.87M |
| ATAI Life Sciences NV | 215.78M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.22M |
| Shareholders Equity (Quarterly) | 30.78M |
| Debt to Equity Ratio | 0.3286 |
| Current Ratio | 2.710 |
| Net Debt Paydown Yield | 1.79% |